DGAP-News: MediClin AG: Sales increased by EUR 5.4 million in the first Quarter of 2012


DGAP-News: MediClin AG / Key word(s): Quarter Results
MediClin AG: Sales increased by EUR 5.4 million in the first Quarter
of 2012

11.05.2012 / 09:46

---------------------------------------------------------------------

Offenburg, May 11, 2012 - MEDICLIN Aktiengesellschaft (MediClin) achieved
Group sales of EUR 125.4 million in the first three months of the new
financial year. Sales were EUR 5.4 million or 4.5 % higher than in the
first quarter of 2011. The largest part of the increase was recorded in the
post-acute segment. Here sales increased by EUR 4.4 million up to EUR 70.7
million. Sales of the acute segment sales rose by EUR 0.2 million up to EUR
50.6 million. The business area nursing care improved sales by EUR 0.3
million up to EUR 3.2 million.

The Group operating result for the first quarter 2011 stood at EUR -0.5
million and included an aperiodic provision for budged risks in the amount
of EUR 1.1 million. Adjusted for this special effect, the Group operating
result for the first quarter 2012, which amounted EUR -1,2 million, is EUR
0.5 million higher than the figure achieved in the previous year.

In the post-acute segment the result improved compared to the first quarter
2011 from EUR -3.3 million to EUR -1.7 million; in the acute segment it
degreased by EUR 2.2 million to EUR 2.4 million due to increased costs.

The financial result enhanced by EUR 0,3 million, therefore the result
attributable to the shareholders of EUR -2,0 million was at the same level
as in the first quarter 2011 lag.

Further company development and outlook 

In 2012 MediClin will invest in a further expansion of capacities and in an
extension of medical services offered based on corresponding demand.

On Group level between MediClin and Askelpios the analysis of possible
common potentials available has started as well as discussions about
location-specific cooperation between the facilities of both holding
companies.

Overall, the Management Board expects an increase in sales in the current
financial year and a solid development of results, insofar as the framework
conditions in the industry and the referral behaviour of the coverage
providers do not seriously change in 2012.

The interim report of the first quarter 2012 is available in German and
English at www.mediclin.de.

  

About MediClin AG (Ticker: MED; WKN: 659 510) 

MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungs-zentren (medical care units) in 11 federal states MediClin has
a total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,300 employees.


End of Corporate News

---------------------------------------------------------------------

11.05.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                               
Company:     MediClin AG                                           
             Okenstraße 27                                         
             77652 Offenburg                                       
             Germany                                               
Phone:       +49 (0)781 488-189                                    
Fax:         +49 (0)781 488-184                                    
E-mail:      alexandra.muehr@mediclin.de                           
Internet:    www.mediclin.de                                       
ISIN:        DE0006595101                                          
WKN:         659510                                                
Listed:      Regulierter Markt in Frankfurt (Prime Standard);      
             Freiverkehr in Berlin, Düsseldorf, Hamburg, München,  
             Stuttgart                                             
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
169357 11.05.2012